Target intelligence / Profile preview

RNA, U6atac small nuclear 29, pseudogene (RNU6ATAC29P)

Target
RNU6ATAC29P
Molecular classification
Other (pseudogene), Small nuclear RNA (snRNA) pseudogene
01

Overview

**RNA, U6atac small nuclear 29, pseudogene (RNU6ATAC29P)** is a pseudogene that encodes a nonfunctional RNA molecule related to small nuclear RNAs (snRNAs). Small nuclear RNAs, when functional, participate in RNA splicing as components of the spliceosome, specifically in the removal of minor class introns. However, as a pseudogene, RNU6ATAC29P is regarded as nonfunctional and does not encode a functional product or participate in known biological pathways. It is not a therapeutic target, enzyme, receptor, transporter, or other classically targeted biomolecule, nor is it implicated in disease pathways or drug interactions[1].\n\n**Additional context:** \n- A **pseudogene** is a segment of DNA resembling a gene but generally nonfunctional due to mutations or lack of regulatory elements, and thus does not produce an active product[1].\n- **Small nuclear RNAs (snRNAs)**, when functional, are part of the spliceosome complex crucial for pre-mRNA splicing, but pseudogenes of snRNA do not contribute to these functions[2][3].\n\nThis entry is not a receptor, enzyme, transporter, transcription factor, or other therapeutic target class. RNU6ATAC29P is designated as a pseudogene and is not druggable or therapeutically actionable[1].

Other names
RNU6ATAC29PRNA, U6atac small nuclear 29, pseudogene

Beyond the preview

Go deeper on RNA, U6atac small nuclear 29, pseudogene (RNU6ATAC29P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6atac small nuclear 29, pseudogene (RNU6ATAC29P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call